The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aadi Bioscience Inc | Common | 00032Q104 | 7,200 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | ||
| Aclaris Therapeutics, Inc. | Common | 00461U105 | 14,144 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | ||
| Aligos Therapeutics Inc | Common | 01626L105 | 3,902 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
| Allakos Inc | Common | 01671P100 | 25,215 | 4,120,134 | SH | SOLE | 4,120,134 | 0 | 0 | ||
| ALX Oncology Holdings Inc | Common | 00166B105 | 40,386 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
| Amyris, Inc | Common | 03236M200 | 22,632 | 7,750,828 | SH | SOLE | 7,750,828 | 0 | 0 | ||
| Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 4,541 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 15,079 | 146,025 | SH | SOLE | 146,025 | 0 | 0 | ||
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 1,701 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | ||
| Astria Therapeutics Inc | Common | 04635X102 | 9,040 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | 14,715 | 2,937,093 | SH | SOLE | 2,937,093 | 0 | 0 | ||
| Bellus Health Inc | Common | 07987C204 | 10,741 | 1,017,152 | SH | SOLE | 1,017,152 | 0 | 0 | ||
| Bolt Therapeutics Inc | Common | 097702104 | 5,730 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | ||
| Celldex Therapeutics Inc | Common | 15117B202 | 5,593 | 198,983 | SH | SOLE | 198,983 | 0 | 0 | ||
| Chinook Therapeutics Inc | Common | 16961L106 | 17,146 | 872,151 | SH | SOLE | 872,151 | 0 | 0 | ||
| Cincor Pharma Inc | Common | 17240Y109 | 11,462 | 349,237 | SH | SOLE | 349,237 | 0 | 0 | ||
| Codexis, Inc | Common | 192005106 | 2,352 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
| Cogent Biosciences Inc | Common | 19240Q201 | 28,108 | 1,883,941 | SH | SOLE | 1,883,941 | 0 | 0 | ||
| Compass Therapeutics Inc | Common | 20454B104 | 4,560 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| DBV Technologies SA | Sponsored ADR | 23306J101 | 4,795 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | ||
| Dyne Therapeutics Inc | Common | 26818M108 | 7,336 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | ||
| Genetron Holdings Ltd | ADS | 37186H100 | 6,351 | 8,124,174 | SH | SOLE | 8,124,174 | 0 | 0 | ||
| Geron Corp | Common | 374163103 | 35,657 | 15,238,095 | SH | SOLE | 15,238,095 | 0 | 0 | ||
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 3,096 | 961,359 | SH | SOLE | 961,359 | 0 | 0 | ||
| Harmony Biosciences Holdings Inc | Common | 413197104 | 150,598 | 3,400,261 | SH | SOLE | 3,400,261 | 0 | 0 | ||
| Homology Medicines, Inc. | Common | 438083107 | 596 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | ||
| Impel NeuroPharma Inc | Common | 45258K109 | 14,049 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | ||
| Instil Bio Inc | Common | 45783C101 | 60,436 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | ||
| IO Biotech Inc | Common | 449778109 | 8,172 | 3,015,545 | SH | SOLE | 3,015,545 | 0 | 0 | ||
| Iovance Biotherapeutics Inc | Common | 462260100 | 6,275 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | ||
| Iveric Bio Inc | Common | 46583P102 | 8,672 | 483,413 | SH | SOLE | 483,413 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc. | Common | 483497103 | 22,252 | 1,533,559 | SH | SOLE | 1,533,559 | 0 | 0 | ||
| Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 9,971 | 244,375 | SH | SOLE | 244,375 | 0 | 0 | ||
| Merus NV | Common | N5749R100 | 8,853 | 442,000 | SH | SOLE | 442,000 | 0 | 0 | ||
| Metacrine Inc | Common | 59101E103 | 71 | 146,426 | SH | SOLE | 146,426 | 0 | 0 | ||
| Minerva Surgical Inc | Common | 60343F106 | 1,762 | 2,215,667 | SH | SOLE | 2,215,667 | 0 | 0 | ||
| Olema Pharmaceuticals Inc | Common | 68062P106 | 4,663 | 1,689,515 | SH | SOLE | 1,689,515 | 0 | 0 | ||
| Precision Biosciences Inc | Common | 74019P108 | 182 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
| Relmada Therapeutics Inc | Common | 75955J402 | 26,404 | 713,238 | SH | SOLE | 713,238 | 0 | 0 | ||
| Rezolute Inc | Common | 76200L309 | 1,341 | 489,473 | SH | SOLE | 489,473 | 0 | 0 | ||
| Satsuma Pharmaceuticals Inc | Common | 80405P107 | 7,394 | 1,232,394 | SH | SOLE | 1,232,394 | 0 | 0 | ||
| Sera Prognostics Inc | Common | 81749D107 | 2,970 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | ||
| Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
| Tarsus Pharmaceuticals Inc | Common | 87650L103 | 38,729 | 2,262,200 | SH | SOLE | 2,262,200 | 0 | 0 | ||
| Terns Pharmaceuticals Inc | Common | 880881107 | 34,747 | 5,899,372 | SH | SOLE | 5,899,372 | 0 | 0 | ||
| Vaxcyte Inc | Common | 92243G108 | 9,708 | 404,508 | SH | SOLE | 404,508 | 0 | 0 | ||
| Ventyx Biosciences Inc | Common | 92332V107 | 47,333 | 1,355,861 | SH | SOLE | 1,355,861 | 0 | 0 | ||
| Vera Therapeutics Inc | Common | 92337R101 | 14,207 | 666,666 | SH | SOLE | 666,666 | 0 | 0 | ||
| Verona Pharma PLC | ADS | 925050106 | 43,434 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | ||
| Viridian Therapeutics Inc | Common | 92790C104 | 34,047 | 1,660,019 | SH | SOLE | 1,660,019 | 0 | 0 | ||
| Zai Lab Ltd ADR | ADR | 98887Q104 | 9,286 | 271,528 | SH | SOLE | 271,528 | 0 | 0 | ||